Generic Name: Esketamine (Nasal Spray)
Brand Name: Spravato
Medication Classification: antidepressant
SPRAVATO® (esketamine) CIII Nasal Spray contains a substance called esketamine. This medicine works in the brain to help improve mood and reduce feelings of sadness. It’s approved by the FDA for certain types of depression and can be very effective for:
Our psychiatric nurse practitioners will talk with you to understand your situation and see if SPRAVATO might be a good fit for you. We’ll also discuss what you hope to achieve with treatment.
Based on your needs, your provider will create a plan for your treatment, including how often you’ll receive the medication and what to expect during each session.
Our trained staff will make sure you receive the medication safely and comfortably in a supervised environment.
We’ll keep track of how you’re doing throughout treatment and make any adjustments needed to ensure you’re getting the best care possible.
No, SPRAVATO® is not available over the counter. It requires a prescription from a healthcare provider for purchase.
The cost of SPRAVATO® can vary depending on factors such as dosage, insurance coverage, and location.
The onset of SPRAVATO’s effects can vary from person to person. Typically, some individuals may start to notice improvement in their symptoms within a few days to weeks of starting treatment. However, it’s essential to follow your healthcare provider’s guidance and continue treatment as prescribed to achieve the best results.
SPRAVATO is not intended for use at home. It should be administered in a supervised medical setting under the guidance of a healthcare professional trained in its use.
he duration of treatment with SPRAVATO can vary depending on individual circumstances and response to the medication. Our healthcare provider will determine the appropriate length of treatment based on your specific needs and response to therapy.
The effectiveness of SPRAVATO varies from person to person and depends on factors such as the severity of the condition being treated and individual response to the medication. Clinical studies have shown that SPRAVATO can be effective in some people with treatment-resistant depression, but the success rate can vary.